Recent Finacing
Recent Raise
Satori Pharmaceuticals develops gamma‑secretase modulators to lower brain amyloid beta 42 and prevent plaque formation, while collaborating on early protein-based diagnostics and preparing IND-directed clinical development.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors